Clasp Therapeutics took off with $150 million in Series A financing to develop a portfolio of next-generation immunotherapies that are both personalized and off-the-shelf to target hard-to-treat tumors. Based in Cambridge, Massachusetts and Rockville, Maryland, the startup garnered attention from…

Tmunity Therapeutics, a new Philadelphia company co-founded by immunotherapy pioneer Dr. Carl June of the University of Pennsylvania’s Perelman School of Medicine, raised $10 million in an equity financing from Penn Medicine and venture capital firm Lilly Asia Ventures. Tmunity…